TSMC Confirms 44% FY26 Revenue Growth and Doubles 2nm Capacity in 2027
Read source articleWhat happened
TSMC now expects full-year 2026 revenue to grow approximately 44%, consistent with July's 44.7% YoY monthly increase and Q2's 36% YoY rise, and plans to more than double annual capacity for 2-nanometer chips in 2027. The news aligns with the company's already raised 2026 capex to $60–64 billion and reflects hyperscaler-driven AI demand that pushed HPC to 66% of Q2 revenue. At $428.9, the stock sits above our $390 attractive entry and near the $470 trim level, leaving limited margin of safety given stretched valuation (28.6x P/E) and overseas-fab margin dilution. The capacity expansion reinforces TSMC's moat but increases execution risk: if hyperscaler commitments soften, the fixed-cost model could compress margins and free cash flow. No change to our WAIT rating: wait for a pullback or clearer evidence that gross margin can hold above 67% while capex remains elevated.
Implication
The confirmation of 44% FY26 revenue growth and doubled 2nm capacity in 2027 strengthens the demand case, but the stock already prices in multi-year AI expansion. With shares at $428.9 against a base-case implied value of $450, upside is limited to ~5%, while downside to bear case $360 is ~16%, yielding unfavorable risk-reward. The main risk is that elevated capex and overseas-fab dilution could pressure gross margin from current 67.7%, especially if hyperscaler capex slows in 1H27. Key near-term checkpoints remain monthly revenue prints sustaining >25% YoY and Q3/Q4 margin commentary, with no change to our 90-day monitoring. Long-term investors should hold existing positions but avoid new buys until either a pullback toward $390 or evidence that 2nm ramp and packaging add enough margin offset to justify current multiples.
Thesis delta
The news reinforces the existing thesis that TSMC benefits from durable AI-driven demand, particularly at leading-edge nodes. It does not shift our WAIT rating because the stock's valuation already reflects this strength and the risks of high capex and margin dilution remain. Confidence in the demand trajectory increases slightly, but no change to the investment call.
Confidence
Medium